Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3935)
All Articles published online
|
Mar 21, 2008 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Deli A, Kreidl E, Santifaller S, Trotter B, Seir K, Berger W, Schulte-Hermann R, Rodgarkia-Dara C, Grusch M. Activins and activin antagonists in hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1699-1709 [PMID: PMC2695910 DOI: 10.3748/wjg.14.1699] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i11/1699.htm |
| Number | Citing Articles |
| 1 |
Foteini Kiagiadaki, Marilena Kampa, Argyro Voumvouraki, Elias Castanas, Elias Kouroumalis, George Notas. Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(3): 891 doi: 10.1016/j.bbadis.2017.12.031
|
| 2 |
Xiao-Ling Wang, Meng Yang, Ying Wang. Roles of transforming growth factor-β signaling in liver disease. World Journal of Hepatology 2024; 16(7): 973-979 doi: 10.4254/wjh.v16.i7.973
|
| 3 |
Maria Gavriatopoulou, Meletios A. Dimopoulos, Efstathios Kastritis, Evangelos Terpos. Emerging treatment approaches for myeloma-related bone disease. Expert Review of Hematology 2017; 10(3): 217 doi: 10.1080/17474086.2017.1283213
|
| 4 |
Prudence Donovan, Olivier A. Dubey, Susanna Kallioinen, Katherine W. Rogers, Katja Muehlethaler, Patrick Müller, Donata Rimoldi, Daniel B. Constam. Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion. Journal of Investigative Dermatology 2017; 137(12): 2578 doi: 10.1016/j.jid.2017.07.845
|
| 5 |
Masahiro Morita, Osamu Hashimoto. Identification and expression of the medaka inhibin βE subunit. Molecular Biology Reports 2019; 46(2): 1603 doi: 10.1007/s11033-019-04607-y
|
| 6 |
Raffaele Addeo, Michele Caraglia, Salvatore Del Prete. Highlights of regional meeting of Italian Southern Oncological Group (GOIM): focus on hepatocellular carcinoma: biological and clinical background, therapeutic guide-lines and perspectives. Expert Opinion on Investigational Drugs 2009; 18(3): 373 doi: 10.1517/14712590802680158
|
| 7 |
Tereza Ventura-Holman, Abulkhair Mamoon, Maria C. Subauste, Jose S. Subauste. The effect of oncoprotein v-erbA on thyroid hormone-regulated genes in hepatocytes and their potential role in hepatocellular carcinoma. Molecular Biology Reports 2011; 38(2): 1137 doi: 10.1007/s11033-010-0211-2
|
| 8 |
S L Webb, C M Edwards. Novel therapeutic targets in myeloma bone disease. British Journal of Pharmacology 2014; 171(16): 3765 doi: 10.1111/bph.12742
|
| 9 |
Ying Shi, Yong Li Bao, Yin Wu, Chun Lei Yu, Yan Xin Huang, Ying Sun, Li Hua Zheng, Yu Xin Li. Alantolactone Inhibits Cell Proliferation by Interrupting the Interaction between Cripto-1 and Activin Receptor Type II A in Activin Signaling Pathway. SLAS Discovery 2011; 16(5): 525 doi: 10.1177/1087057111398486
|
| 10 |
Ansgar Brüning, Christina Matsingou, German Johannes Brem, Martina Rahmeh, Ioannis Mylonas. Inhibin beta E is upregulated by drug-induced endoplasmic reticulum stress as a transcriptional target gene of ATF4. Toxicology and Applied Pharmacology 2012; 264(2): 300 doi: 10.1016/j.taap.2012.08.011
|
| 11 |
Shivani Priya, Lakhon Kma. Identification of novel microRNAs: Biomarkers for pathogenesis of hepatocellular carcinoma in mice model. Biochemistry and Biophysics Reports 2025; 41: 101896 doi: 10.1016/j.bbrep.2024.101896
|
| 12 |
Farshid Zandsalimi, Zahra Hajihassan, Roghaye Hamidi. Denovo designing: a novel signal peptide for tat translocation pathway to transport activin A to the periplasmic space of E. coli. Biotechnology Letters 2020; 42(1): 45 doi: 10.1007/s10529-019-02752-9
|
| 13 |
German Santamaria Rodriguez, Alvaro Morales Prado. Ulcerative colitis and lymphoproliferative. Gastroenterology & Hepatology: Open Access 2019; 10(3): 132 doi: 10.15406/ghoa.2019.10.00371
|
| 14 |
JIANWEI ZHU, FAN LIU, QUANMING WU, XIANCHENG LIU. Activin A regulates proliferation, invasion and migration in osteosarcoma cells. Molecular Medicine Reports 2015; 11(6): 4501 doi: 10.3892/mmr.2015.3284
|
| 15 |
K Frost, K Seir, A Lackner, M Grusch, B Grasl-Kraupp, R Schulte-Hermann, C Rodgarkia-Dara. Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma?. British Journal of Cancer 2011; 104(8): 1303 doi: 10.1038/bjc.2011.53
|
| 16 |
Karen A. Dunphy, Alan L. Schneyer, Mary J. Hagen, D. Joseph Jerry. The Role of Activin in Mammary Gland Development and Oncogenesis. Journal of Mammary Gland Biology and Neoplasia 2011; 16(2): 117 doi: 10.1007/s10911-011-9214-4
|
| 17 |
Massimiliano Paganelli, Omar Nyabi, Brice Sid, Jonathan Evraerts, Imane El Malmi, Yves Heremans, Laurent Dollé, Carley Benton, Pedro-Buc Calderon, Leo van Grunsven, Harry Heimberg, David Campard, Etienne Sokal, Mustapha Najimi. Downregulation of Sox9 Expression Associates with Hepatogenic Differentiation of Human Liver Mesenchymal Stem/Progenitor Cells. Stem Cells and Development 2014; 23(12): 1377 doi: 10.1089/scd.2013.0169
|
| 18 |
Jonas Santol, David Pereyra, Stefanie Haegele, Daphni Ammon, Gregor Ortmayr, Anita Pirabe, Jan Philipp Jonas, Stefan Schuster, Sarang Kim, Toni Nguyen, Thomas Gruenberger, Alice Assinger, Patrick Starlinger. The Ratio of Activin A and Follistatin-Like 3 Is Associated With Posthepatectomy Liver Failure and Morbidity in Patients Undergoing Liver Resection. Gastro Hep Advances 2023; 2(5): 642 doi: 10.1016/j.gastha.2023.02.011
|
| 19 |
Zi-Bin Xu, Mei-Fu Gan, Hong-Yuan Yu, Li-Cai Mo, Yu-Hui Xia, Qing-Xin Yu, Jing-Min Zheng. The Significance of INHBE Expression in the Cancer Cells of Clear-Cell Renal Cell Carcinoma. Urologia Internationalis 2022; 106(4): 376 doi: 10.1159/000518161
|
| 20 |
Emanuel Kreidl, Deniz Öztürk, Thomas Metzner, Walter Berger, Michael Grusch. Activins and follistatins: Emerging roles in liver physiology and cancer. World Journal of Hepatology 2009; 1(1): 17-27 doi: 10.4254/wjh.v1.i1.17
|
| 21 |
Sutada Lotinun, R. Scott Pearsall, Monique V. Davies, Tod H. Marvell, Travis E. Monnell, Jeffrey Ucran, Roberto J. Fajardo, Ravindra Kumar, Kathryn W. Underwood, Jasbir Seehra, Mary L. Bouxsein, Roland Baron. A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys. Bone 2010; 46(4): 1082 doi: 10.1016/j.bone.2010.01.370
|
| 22 |
K. Breuhahn, P. Schirmacher. Development, Differentiation and Disease of the Para-Alimentary Tract. Progress in Molecular Biology and Translational Science 2010; 97: 251 doi: 10.1016/B978-0-12-385233-5.00009-X
|
| 23 |
Tsima Abou Kors, Linda Hofmann, Annika Betzler, Kathrina Payer, Martin Bens, Jens Truong, Adrian von Witzleben, Jaya Thomas, Johann M. Kraus, Randa Kalaajieh, Diana Huber, Jasmin Ezić, Julian Benckendorff, Jens Greve, Patrick J. Schuler, Christian H. Ottensmeier, Hans A. Kestler, Thomas K. Hoffmann, Marie-Nicole Theodoraki, Cornelia Brunner, Simon Laban.
INHBA is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression. Cancer Research Communications 2024; 4(2): 571 doi: 10.1158/2767-9764.CRC-23-0258
|
| 24 |
John T. Hardy, Irina A. Buhimschi, Megan E. McCarthy, Guomao Zhao, Christine A. Laky, Lydia L. Shook, Catalin S. Buhimschi. Imbalance of Amniotic Fluid Activin-A and Follistatin in Intraamniotic Infection, Inflammation, and Preterm Birth. The Journal of Clinical Endocrinology & Metabolism 2016; 101(7): 2785 doi: 10.1210/jc.2015-4147
|
| 25 |
Osamu Hashimoto, Masayuki Funaba. Activins and Inhibins. Vitamins & Hormones 2011; 85: 217 doi: 10.1016/B978-0-12-385961-7.00011-1
|
| 26 |
Edward Ottley, Elspeth Gold. Insensitivity to the growth inhibitory effects of activin A: An acquired capability in prostate cancer progression. Cytokine & Growth Factor Reviews 2012; 23(3): 119 doi: 10.1016/j.cytogfr.2012.04.004
|
| 27 |
Gaetano Leto. Activin A and bone metastasis. Journal of Cellular Physiology 2010; 225(2): 302 doi: 10.1002/jcp.22272
|
| 28 |
Arne Yndestad, John Willy Haukeland, Tuva B. Dahl, Bente Halvorsen, Pål Aukrust. Activins and Inhibins. Vitamins & Hormones 2011; 85: 323 doi: 10.1016/B978-0-12-385961-7.00015-9
|
| 29 |
Yuan-Yuan Zhang, Harry Hua-Xiang Xia. Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fiction. World Journal of Gastroenterology 2008; 14(11): 1641-1642 doi: 10.3748/wjg.14.1641
|
| 30 |
Mohsin Bashir, Surekha Damineni, Geetashree Mukherjee, Paturu Kondaiah. Activin-A signaling promotes epithelial–mesenchymal transition, invasion, and metastatic growth of breast cancer. npj Breast Cancer 2015; 1(1) doi: 10.1038/npjbcancer.2015.7
|
| 31 |
Z-B Song, P Wu, J-S Ni, T Liu, C Fan, Y-L Bao, Y Wu, L-G Sun, C-L Yu, Y-X Huang, Y-X Li. Testes-specific protease 50 promotes cell proliferation via inhibiting activin signaling. Oncogene 2017; 36(43): 5948 doi: 10.1038/onc.2017.198
|
| 32 |
Rostyslav V. Bubnov, Maria V. Drahulian, Polina V. Buchek, Tamara P. Gulko. High regenerative capacity of the liver and irreversible injury of male reproductive system in carbon tetrachloride-induced liver fibrosis rat model. EPMA Journal 2018; 9(1): 59 doi: 10.1007/s13167-017-0115-5
|
| 33 |
Jamie L. Fox, Michael Dews, Andy J. Minn, Andrei Thomas-Tikhonenko. Targeting of TGFβ signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma. RNA 2013; 19(2): 177 doi: 10.1261/rna.036467.112
|
| 34 |
Stephen Nesnow, William Ward, Tanya Moore, Hongzu Ren, Susan D. Hester. Discrimination of Tumorigenic Triazole Conazoles from Phenobarbital by Transcriptional Analyses of Mouse Liver Gene Expression. Toxicological Sciences 2009; 110(1): 68 doi: 10.1093/toxsci/kfp076
|
| 35 |
Amon Asgharpour, Sophie C. Cazanave, Tommy Pacana, Mulugeta Seneshaw, Robert Vincent, Bubu A. Banini, Divya Prasanna Kumar, Kalyani Daita, Hae-Ki Min, Faridoddin Mirshahi, Pierre Bedossa, Xiaochen Sun, Yujin Hoshida, Srinivas V. Koduru, Daniel Contaifer, Urszula Osinska Warncke, Dayanjan S. Wijesinghe, Arun J. Sanyal. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. Journal of Hepatology 2016; 65(3): 579 doi: 10.1016/j.jhep.2016.05.005
|
| 36 |
Mai Abdel Mouti, Siim Pauklin. TGFB1/INHBA Homodimer/Nodal-SMAD2/3 Signaling Network: A Pivotal Molecular Target in PDAC Treatment. Molecular Therapy 2021; 29(3): 920 doi: 10.1016/j.ymthe.2021.01.002
|
| 37 |
Boyang Liu, Linjing Zhu, Linfang Bian, Dezhong Wen, Xueling Cui. Recent advances in the dual effects of activin A on tumors. Biochemical and Biophysical Research Communications 2025; 747: 151301 doi: 10.1016/j.bbrc.2025.151301
|
| 38 |
Sann Sanda Khin, Riko Kitazawa, Ne Win, Than Than Aye, Kiyoshi Mori, Takeshi Kondo, Sohei Kitazawa. BAMBI gene is epigenetically silenced in subset of high‐grade bladder cancer. International Journal of Cancer 2009; 125(2): 328 doi: 10.1002/ijc.24318
|
| 39 |
Deng-Yong Zhang, Jia-Sheng Lei, Wan-Liang Sun, Dong-Dong Wang, Zheng Lu. Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma. Chinese Medical Journal 2020; 133(15): 1798 doi: 10.1097/CM9.0000000000000847
|
| 40 |
Sowmya Mekala, Ravi Rai, Samantha Loretta Reed, Bill Bowen, George K. Michalopoulos, Joseph Locker, Reben Raeman, Michael Oertel. Antagonizing Activin A/p15INK4b Signaling as Therapeutic Strategy for Liver Disease. Cells 2024; 13(7): 649 doi: 10.3390/cells13070649
|
| 41 |
Magdalena Heinz, Heide Leb Niederleithner, Emmi Puujalka, Ana Soler-Cardona, Michael Grusch, Hubert Pehamberger, Robert Loewe, Peter Petzelbauer. Activin A Is Anti-Lymphangiogenic in a Melanoma Mouse Model. Journal of Investigative Dermatology 2015; 135(1): 212 doi: 10.1038/jid.2014.328
|
| 42 |
Joanne L. Hopper, Natasha Begum, Laura Smith, Thomas A. Hughes. The role of PSMD9 in human disease: future clinical and therapeutic implications. AIMS Molecular Science 2015; 2(4): 476 doi: 10.3934/molsci.2015.4.476
|
| 43 |
Sooyeon Oh, Jooho Lee. Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma. Clinical and Molecular Hepatology 2020; 26(4): 476 doi: 10.3350/cmh.2020.0192
|
| 44 |
Lingling Jiang, Boyang Liu, Yan Qi, Linru Zhu, Xueling Cui, Zhonghui Liu. Antagonistic effects of activin A and TNF-α on the activation of L929 fibroblast cells via Smad3-independent signaling. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77783-8
|
| 45 |
Xue Gao, Pan Zhao, Jie Hu, Hongguang Zhu, Jiming Zhang, Zhongwen Zhou, Jingmin Zhao, Feng Tang. MicroRNA‐194 protects against chronic hepatitis B‐related liver damage by promoting hepatocyte growth via ACVR2B. Journal of Cellular and Molecular Medicine 2018; 22(9): 4534 doi: 10.1111/jcmm.13714
|
| 46 |
Enrrico Bloise, Henrique L Couto, Lauretta Massai, Pasquapina Ciarmela, Marzia Mencarelli, Lavinia E Borges, Michela Muscettola, Giovanni Grasso, Vania F Amaral, Geovanni D Cassali, Felice Petraglia, Fernando M Reis. Differential expression of follistatin and FLRG in human breast proliferative disorders. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-320
|
| 47 |
Martine A Thomis, Jeroen Aerssens. Genetic variation in human muscle strength—opportunities for therapeutic interventions?. Current Opinion in Pharmacology 2012; 12(3): 355 doi: 10.1016/j.coph.2012.03.003
|
| 48 |
Andreia Bufalino, Nilva K. Cervigne, Carine Ervolino de Oliveira, Felipe Paiva Fonseca, Priscila Campioni Rodrigues, Carolina Carneiro Soares Macedo, Lays Martin Sobral, Marcia Costa Miguel, Marcio Ajudarte Lopes, Adriana Franco Paes Leme, Daniel W. Lambert, Tuula A. Salo, Luiz Paulo Kowalski, Edgard Graner, Ricardo D. Coletta, Xin-Yuan Guan. Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis. PLOS ONE 2015; 10(8): e0136599 doi: 10.1371/journal.pone.0136599
|
| 49 |
Ansgar Brüning, German J. Brem, Marianne Vogel, Ioannis Mylonas. Tetracyclines cause cell stress-dependent ATF4 activation and mTOR inhibition. Experimental Cell Research 2014; 320(2): 281 doi: 10.1016/j.yexcr.2013.11.012
|
| 50 |
Enoch Appiah Adu-Gyamfi, Yu-Bin Ding, Ying-Xiong Wang. Regulation of placentation by the transforming growth factor beta superfamily†. Biology of Reproduction 2020; 102(1): 18 doi: 10.1093/biolre/ioz186
|
| 51 |
Liangchang Hu, Yu Zhao, Xuguang Zhang, Chunhui Ma. Activin A promoted the anti‐tumor effect of ActRIIA high CD8+ T cells in mouse hepatoma. Cancer Medicine 2025; 14(1) doi: 10.1002/cam4.70147
|
| 52 |
Katharina Sinn, Ahmed Elbeialy, Berta Mosleh, Clemens Aigner, Karin Schelch, Viktoria Laszlo, Balazs Dome, Mir Alireza Hoda, Michael Grusch. High circulating activin A plasma levels are associated with tumour stage and poor survival in treatment-naive lung squamous cell cancer patients. Translational Oncology 2025; 51: 102153 doi: 10.1016/j.tranon.2024.102153
|
| 53 |
Jun Nakahodo, Yuki Fukumura, Tsuyoshi Saito, Kenichi Hirabayashi, Reiko Doi, Takuo Hayashi, Takashi Yao. Upregulation of follistatin and low apoptotic activity in intraductal oncocytic papillary neoplasm of the pancreatobiliary system. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-64920-6
|
| 54 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3159 doi: 10.1007/978-3-319-26956-6_173
|
| 55 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_173-1
|
| 56 |
Jin-Ting He, Jing Mang, Chun-Li Mei, Le Yang, Jiao-Qi Wang, Ying Xing, Hong Yang, Zhong-Xin Xu. Neuroprotective Effects of Exogenous Activin A on Oxygen-Glucose Deprivation in PC12 Cells. Molecules 2011; 17(1): 315 doi: 10.3390/molecules17010315
|